# Dr. Mey Boukenna

> Dr. Mey Boukenna is a Series B investor at The Pags Group backing Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [The Pags Group](https://shizune.co/investors/profile/the-pags-group)
- Total investments: 1
- Last investment: Jan 2024
- Lead investor: 0%
- Last updated: Aug 2026

Dr. Mey Boukenna is a Series B investor at The Pags Group focused on Pharmaceutical. Dr. Mey Boukenna

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ratio Therapeutics | Ratio Therapeutics develops radiotherapeutics for the treatment of cancers. They engaged in research and development platforms, trillium and macropa, enable the imaging, discovery, and advancement of radiopharmaceuticals. It enables doctors to detect a wide range of epithelial-derived cancers, such as breast, pancreatic, lung, colon cancers, andmore. | $50M | Series B | Jan 17, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [Bristol-Myers Squibb](https://shizune.co/investors/profile/bristol-myers-squibb) — VC Fund, 1 deal together
- [Cornell University](https://shizune.co/investors/profile/cornell-university) — VC Fund, 1 deal together
- [Duquesne Capital Management](https://shizune.co/investors/profile/duquesne-capital-management) — VC Fund, 1 deal together
- [Schusterman Family Investments](https://shizune.co/investors/profile/schusterman-family-investments) — VC Fund, 1 deal together

## About The Pags Group

VC Fund

The Pags Group operates as the family office of Stephen Pagliuca.

2 contacts available at The Pags Group.

| Name | Title | Profile |
| --- | --- | --- |
| Dr. Mey Boukenna | president | https://shizune.co/investors/profile/dr-mey-boukenna |
| Stephen Pagliuca | Founder | https://shizune.co/investors/profile/stephen-g-pagliuca |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Dr. Mey Boukenna invest in?

Dr. Mey Boukenna invests primarily in Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dr. Mey Boukenna last invest?

The most recent investment recorded for Dr. Mey Boukenna closed in Jan 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co